The Outcome of Patients with Hodgkin Lymphoma and Early Relapse after Autologous Stem Cell Transplant Has Improved in Recent Years

Scientists analyzed 1781 adult Hodgkin lymphoma patients who relapsed between 2006 and 2017 after a first autologous-stem-cell- transplantation. The four-year overall survival (OS) after relapse continuously increased from 32% for patients relapsing in 2006–2008, to 63% for patients relapsing in 2015–201.7